Policy and Legislation

According to a recent report from HHS, 1,200 prescription drug prices increased faster than inflation in 2021.

The discussion about Medicare cuts is heating up, and insurers are confident their estimates are more accurate than those from CMS.

The group says it would support a "smooth transition" back to normal Medicaid eligibility during the redetermination process.

The lawmakers say that while some insurance companies are complying with CMS' rule, others may be relying on gaps to evade accountability.

They want the federal government to bolster financial assistance policies and protect people from certain billing and collection practices.

The groups maintained that additional cuts to Medicaid would only cause further difficulties on the heels of the COVID-19 pandemic.

Lower COVID-19 costs and better results in the individual market contributed to insurers' strong performance.

A representative from the DEA was invited to attend the special listening session.

The reduction in private insurance premiums, BCBSA found, would increase federal tax revenues by about $29 billion.

Ellison Institute director of policy, Gabriel Seidman, talks about the institute's work in creating a country-wide enterprise architecture for healthcare data that encompasses clinical, social determinants and public health data.